【结 构 式】 |
【分子编号】50254 【品名】3-([[5-(aminocarbonyl)-1-methyl-3-propyl-1H-pyrazol-4-yl]amino]carbonyl)-4-propoxybenzenesulfonyl chloride 【CA登记号】 |
【 分 子 式 】C18H23ClN4O5S 【 分 子 量 】442.92328 【元素组成】C 48.81% H 5.23% Cl 8% N 12.65% O 18.06% S 7.24% |
合成路线1
该中间体在本合成路线中的序号:(V)The reaction of 2-propoxybenzoic acid (I) with SOCl2 in refluxing dichloromethane gives the acyl chloride (II), which is condensed with 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide (III) by means of TEA and DMAP in dichloromethane to yield the carboxamide (IV). The sulfonation of (IV) with chlorosulfonic acid affords the benzenesulfonyl chloride (V), which is treated with 2-(1-methylpyrrolidin-2-yl)ethylamine (VI) in dichloromethane to afford the sulfonamide (VII). Finally, this compound is cyclized by means of tBu-OK in refluxing tert-butanol to provide the target pyrazolo-pyrimidininone.
【1】 Kim, S.-H.; Chang, M.-S.; Kim, D.-S.; Yoo, M.-H.; Kim, W.-B.; Bae, C.-J.; Kim, Y.-D.; Kim, E.-H. (Dong-A Pharmaceutical Co., Ltd.); A process for preparing pyrazolopyrimidinone derivs. for the treatment of impotence. WO 0198304 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 53952 | 2-n-Propoxybenzoic acid | 2100-31-4 | C10H12O3 | 详情 | 详情 |
(II) | 53953 | 2-propoxybenzoyl chloride | C10H11ClO2 | 详情 | 详情 | |
(III) | 15627 | 4-amino-1-methyl-3-propyl-1H-pyrazole-5-carboxamide; 4-amino-1-methyl-3-propyl-5-pyrazolecarboxamide | 139756-02-8 | C8H14N4O | 详情 | 详情 |
(IV) | 50253 | 1-methyl-4-[(2-propoxybenzoyl)amino]-3-propyl-1H-pyrazole-5-carboxamide | C18H24N4O3 | 详情 | 详情 | |
(V) | 50254 | 3-([[5-(aminocarbonyl)-1-methyl-3-propyl-1H-pyrazol-4-yl]amino]carbonyl)-4-propoxybenzenesulfonyl chloride | C18H23ClN4O5S | 详情 | 详情 | |
(VI) | 53954 | 2-(2-Aminoethyl)-1-methylpyrrolidine | n/a | C7H16N2 | 详情 | 详情 |
(VII) | 53955 | 1-methyl-4-{[5-({[2-(1-methyl-2-pyrrolidinyl)ethyl]amino}sulfonyl)-2-propoxybenzoyl]amino}-3-propyl-1H-pyrazole-5-carboxamide | C25H38N6O5S | 详情 | 详情 |
合成路线2
该中间体在本合成路线中的序号:(II)Chlorosulfonylation of the benzamidopyrazole (I) to give (II) was performed with neat chlorosulfonic acid at 0 C. Coupling of sulfonyl chloride (II) with the piperidinopropanoate (III) provided sulfonamide (IV). Finally, cyclization of (IV) with concomitant ester hydrolysis under basic conditions furnished the target pyrazolopyrimidine.
【1】 Kim, D.-K.; et al.; Synthesis and phosphodiesterase inhibitory activity of new sildenafil analogues containing a carboxylic acid group in the 5'-sulfonamide moiety of a phenyl ring. Bioorg Med Chem 2001, 9, 11, 3013. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 50253 | 1-methyl-4-[(2-propoxybenzoyl)amino]-3-propyl-1H-pyrazole-5-carboxamide | C18H24N4O3 | 详情 | 详情 | |
(II) | 50254 | 3-([[5-(aminocarbonyl)-1-methyl-3-propyl-1H-pyrazol-4-yl]amino]carbonyl)-4-propoxybenzenesulfonyl chloride | C18H23ClN4O5S | 详情 | 详情 | |
(III) | 50255 | ethyl 3-(4-piperidinyl)propanoate | C10H19NO2 | 详情 | 详情 | |
(IV) | 50256 | ethyl 3-(1-[[3-([[5-(aminocarbonyl)-1-methyl-3-propyl-1H-pyrazol-4-yl]amino]carbonyl)-4-propoxyphenyl]sulfonyl]-4-piperidinyl)propanoate | C28H41N5O7S | 详情 | 详情 |